International
Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Business
If approved, it will mark the firm's first independent clinical trial with a proprietary extract
Canada
Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects
Canada
The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say
Psychedelics
Currently treatments are largely insufficient, so care providers encourage more research despite stigma
Canada
Psychedelics firm Numinus says amendments made to the country's Special Access Programme come into effect in January
Business
The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials
Business
The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services
Business
The methods will be available as part of third-party client services
Psychedelics
Some are criticizing researcher Stamets for trying to capitalize on the phenomenon of 'stacking,' where psychedelics are paired with health supplements
